Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology

Authors :: Hayriye Sarıcaoğlu
Serap Utaş
Ülker Gül
Emel Bülbül Başkan
Teoman Erdem
Zerrin Ogretmen
Sibel Alper
Oktay Taşkapan
Yasemin Erdem
Andac Salman
Rafet Koca
Filiz Canpolat
Özlem Su Küçük
Esen Özkaya
Emek Kocatürk
Nilgün Atakan
Murat Borlu
Ekin Şavk
Selda Pelin Kartal
Alper, Sibel
Göncü, Özgür Emek Kocatürk (ORCID 0000-0003-2801-0959 & YÖK ID 217219)
Salman, Andaç
Atakan, Nilgün
Başkan, Emel Bülbül
Borlu, Murat
Canpolat, Filiz
Erdem, Teoman
Erdem, Yasemin
Gül, Ülker
Kartal, Selda Pelin
Koca, Rafet
Küçük, Özlem Su
Öğretmen, Zerrin
Özkaya, Esen
Sarıcaoğlu, Hayriye
Savk, Ekin
Taşkapan, Oktay
Utas, Serap
School of Medicine
KÜÇÜK, Özlem Su
Source :: Turkderm-Turkish Archives of Dermatology and Venereology / Türkderm-Türk Deri Hastalıkları ve Frengi Arşivi, Türkderm, Vol 54, Iss 2, Pp 71-75 (2020)
Publication Year :: 2020
Publisher :: Galenos Yayinevi, 2020.
Abstract: NA

Subjects :: medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Statement (logic)
Turkish
lcsh:RC870-923
Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology-, TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, cilt.54, ss.71-75, 2020 [SALMAN A., Alper S., Atakan N., BÜLBÜL BAŞKAN E., BORLU M., Canpolat F., Erdem T., Erdem Y., Gul U., Kartal S. P. , et al., -Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic]
urticaria
dupilumab
Pandemic
lcsh:Dermatology
medicine
Atopic dermatitis
COVID-19
Dupilumab
Omalizumab
Treatment
Urticaria
atopic dermatitis
treatment
Medicine
Dermatology
business.industry
lcsh:RL1-803
lcsh:Diseases of the genitourinary system. Urology
medicine.disease
language.human_language
covid-19
language
omalizumab
business

Full Text Access

Tools